Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?
Funding
Acknowledgments
Conflicts of Interest
References
- Latella, G.; Di Gregorio, J.; Flati, V.; Rieder, F.; Lawrance, I.C. Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scand J. Gastroenterol. 2015, 50, 53–65. [Google Scholar] [CrossRef] [PubMed]
- Rieder, F.; Latella, G.; Magro, F.; Yuksel, E.S.; Higgins, P.D.; Di Sabatino, A.; de Bruyn, J.R.; Rimola, J.; Brito, J.; Bettenworth, D.; et al. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. J. Crohns Colitis 2016, 10, 873–885. [Google Scholar] [CrossRef] [PubMed]
- Nathan, S.D.; Costabel, U.; Glaspole, I.; Glassberg, M.K.; Lancaster, L.H.; Lederer, D.J.; Pereira, C.A.; Trzaskoma, B.; Morgenthien, E.A.; Limb, S.L.; et al. Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis. Chest 2019, 155, 712–719. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cui, Y.; Zhang, M.; Leng, C.; Blokzijl, T.; Jansen, B.H.; Dijkstra, G.; Faber, K.N. Pirfenidone Inhibits Cell Proliferation and Collagen I Production of Primary Human Intestinal Fibroblasts. Cells 2020, 9, 775. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kadir, S.I.; Wenzel Kragstrup, T.; Dige, A.; Kok Jensen, S.; Dahlerup, J.F.; Kelsen, J. Pirfenidone inhibits the proliferation of fibroblasts from patients with active Crohn’s disease. Scand. J. Gastroenterol. 2016, 51, 1321–1325. [Google Scholar] [CrossRef] [PubMed]
- Iswandana, R.; Pham, B.T.; Suriguga, S.; Luangmonkong, T.; van Wijk, L.A.; Jansen, Y.J.M.; Oosterhuis, D.; Mutsaers, H.A.M.; Olinga, P. Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs. Inflamm. Bowel Dis. 2020, 26, 678–686. [Google Scholar] [CrossRef] [PubMed]
- Sun, Y.; Zhang, Y.; Chi, P. Pirfenidone suppresses TGF-β1-induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway. Mol. Med. Rep. 2018, 18, 3907–3913. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kurahara, L.H.; Hiraishi, K.; Hu, Y.; Koga, K.; Onitsuka, M.; Doi, M.; Aoyagi, K.; Takedatsu, H.; Kojima, D.; Fujihara, Y. Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn’s Disease. Cell. Mol. Gastroenterol. Hepatol. 2017, 5, 299–318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sun, Y.W.; Zhang, Y.Y.; Ke, X.J.; Wu, X.J.; Chen, Z.F.; Chi, P. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway. Eur. J. Pharmacol. 2018, 822, 199–206. [Google Scholar] [CrossRef] [PubMed]
- Li, G.; Ren, J.; Hu, Q.; Deng, Y.; Chen, G.; Guo, K.; Li, R.; Li, Y.; Wu, L.; Wang, G.; et al. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model. Biochem. Pharmacol. 2016, 117, 57–67. [Google Scholar] [CrossRef] [PubMed]
- Meier, R.; Lutz, C.; Cosín-Roger, J.; Fagagnini, S.; Bollmann, G.; Hünerwadel, A.; Mamie, C.; Lang, S.; Tchouboukov, A.; Weber, F.E.; et al. Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis. Inflamm. Bowel. Dis. 2016, 22, 569–582. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Latella, G.; Viscido, A. Controversial Contribution of Th17/IL-17 toward the Immune Response in Intestinal Fibrosis. Dig. Dis. Sci. 2020, 65, 1299–1306. [Google Scholar] [CrossRef] [PubMed]
- Fiddler, C.A.; Simler, N.; Parfrey, H.; Miremadi, A.; Chilvers, E.R. Severe Colitis Associated with Pirfenidone Use in Idiopathic Pulmonary Fibrosis. Ann. Am. Thorac. Soc. 2016, 13, 1430–1432. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Latella, G.; Viscido, A. Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis? Cells 2020, 9, 1762. https://doi.org/10.3390/cells9081762
Latella G, Viscido A. Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis? Cells. 2020; 9(8):1762. https://doi.org/10.3390/cells9081762
Chicago/Turabian StyleLatella, Giovanni, and Angelo Viscido. 2020. "Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?" Cells 9, no. 8: 1762. https://doi.org/10.3390/cells9081762